Abstract
Bronchiolitis is a common lower respiratory tract infection of infancy where management has varied considerably in the past. The aim of the present study was to determine whether patient treatment and outcomes changed after introduction of a clinical care pathway. Infants aged up to 6 months admitted to hospital with bronchiolitis were identified as part of an annual audit of bronchiolitis management between winters 2003/2004 and 2009/2010. The primary outcome, duration of stay (DOS), was compared before and after the clinical pathway was introduced before the winter 2005/2006. There were 328 infants identified, mean age 75 days, respiratory syncitial virus was detected in 89%. After the clinical pathway was introduced, the proportion of infants prescribed salbutamol fell from 50% to 8% (p < 0.001) and ipratropium bromide from 38% to 0% (p < 0.001) but the proportion prescribed antibiotics was unchanged. The median DOS was 79 h prior to the clinical pathway and 66 h afterwards (p = 0.010) but there was no difference in days where supplemental oxygen or nasogastric feeding was required. Conclusions. A clinical pathway for the management of acute bronchiolitis can be implemented in the hospital setting and the conservative approach, in particular not prescribing bronchodilators, is not associated with prolonged duration of stay.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis (2006) Diagnosis and management of bronchiolitis. Pediatr 118:1774–1793
Behrendt CE, Decker MD, Burch DJ, Watson PH (1998) International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Paediatr 157:215–220
Brand PL, Vaessen-Verberne AA (2000) Differences in management of bronchiolitis between hospitals in The Netherlands. Dutch Paediatric Respiratory Society. Eur J PaediatrJ 159:343–347
Chavasse RJ, Bastian-Lee Y, Seddon P (2002) How do we treat wheezing infants? Evidence or anecdote. Arch Dis Child 87:546–547
Cheney J, Barber S, Altamirano L, Medico C, Cheney M, Williams C, Jackson M, Yates P, O'Rourke P, Wainwright C (2005) A clinical pathway for bronchiolitis is effective in reducing readmission rates. J Paediatr 147:622–626
Herland K, Akselsen JP, Skjonsberg OH, Bjermer L (2005) How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? Respir Med 99:11–19
Kimpen JL, Schaad UB (1997) Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediatr Infect Dis J 16:479–481
King WJ, Le Saux N, Sampson M, Gaboury I, Norris M, Mohe D (2007) Effect of point of care information on inpatient management of bronchiolitis. BMC Pediatr 7
Prendiville A, Green S, Silverman M (1987) Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax 42:86–91
Scottish Intercollegiate Guideline Network. 2006. Bronchiolitis in children. NHS Quality Improvement Scotland.
Tie SW, Hall GL, Peter S, Vine J, Verheggen M, Pascoe EM, Wilson AC, Chaney G, Stick SM, Martin AC (2009) Home oxygen for children with acute bronchiolitis. Arch Dis Child 94:641–643
Wang EE, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, Langley JM, McDonald J, MacDonald NE, Mitchell I (1996) Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 129:390–395
Willson DF, Horn SD, Hendley JO, Smout R, Gassaway J (2001) Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatr 108:851–855
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP (2008) Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 4
Acknowledgements
The authors would like to thank the following colleagues who assisted in data extraction: Sandy Alexander (2003/2004), Wei Ming (2004/2005 and 2005/2006), Gillian Pearson (2006/2007) and Fiona Cameron (2007/2008). We are also grateful to Stuart Pate and colleagues at the Glasgow Royal Hospital for Sick Children for sharing their clinical pathway with us. Finally we would like to thank the staff in NHS Grampian Clinical Effectiveness for their assistance in this series of audits.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walker, C., Danby, S. & Turner, S. Impact of a bronchiolitis clinical care pathway on treatment and hospital stay. Eur J Pediatr 171, 827–832 (2012). https://doi.org/10.1007/s00431-011-1653-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-011-1653-9